Calliditas Therapeutics AB (publ) (CALTX.ST)
SEK 208.0
(0.87%)
SEK 208.0
(0.87%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 20.42 Million SEK | 460.13% |
| 2022 | 3.64 Million SEK | 310.24% |
| 2021 | 889 Thousand SEK | 0.0% |
| 2020 | - SEK | -100.0% |
| 2019 | 18.68 Million SEK | 1374.62% |
| 2018 | -1.46 Million SEK | 0.0% |
| 2017 | - SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| 2015 | - SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 29.3 Million SEK | 43.45% |
| 2024 Q2 | 40.16 Million SEK | 37.06% |
| 2023 FY | 20.42 Million SEK | 460.13% |
| 2023 Q3 | 16 Million SEK | -9.56% |
| 2023 Q2 | 17.69 Million SEK | 45.53% |
| 2023 Q1 | 12.16 Million SEK | 233.42% |
| 2023 Q4 | 20.42 Million SEK | 27.64% |
| 2022 Q2 | 730 Thousand SEK | -35.57% |
| 2022 FY | 3.64 Million SEK | 310.24% |
| 2022 Q1 | 1.13 Million SEK | 27.45% |
| 2022 Q3 | 582 Thousand SEK | -20.27% |
| 2022 Q4 | 3.64 Million SEK | 526.63% |
| 2021 Q1 | -40.52 Million SEK | 0.0% |
| 2021 FY | 889 Thousand SEK | 0.0% |
| 2021 Q4 | 889 Thousand SEK | 0.0% |
| 2021 Q3 | - SEK | 100.0% |
| 2021 Q2 | -27.27 Million SEK | 32.69% |
| 2020 Q1 | - SEK | -100.0% |
| 2020 Q2 | - SEK | 0.0% |
| 2020 FY | - SEK | -100.0% |
| 2020 Q4 | - SEK | 0.0% |
| 2020 Q3 | - SEK | 0.0% |
| 2019 Q1 | - SEK | 0.0% |
| 2019 Q4 | 18.68 Million SEK | 0.0% |
| 2019 Q3 | - SEK | 0.0% |
| 2019 Q2 | - SEK | 0.0% |
| 2019 FY | 18.68 Million SEK | 1374.62% |
| 2018 FY | -1.46 Million SEK | 0.0% |
| 2018 Q4 | - SEK | 0.0% |
| 2018 Q2 | - SEK | 0.0% |
| 2018 Q1 | - SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2017 Q4 | - SEK | 0.0% |
| 2017 FY | - SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| NextCell Pharma AB | 545.23 Thousand SEK | -3646.628% |
| Biovica International AB (publ) | 2.19 Million SEK | -828.968% |
| Abliva AB (publ) | - SEK | -Infinity% |
| Active Biotech AB (publ) | -2500.00 SEK | 817220.0% |
| Aptahem AB (publ) | - SEK | -Infinity% |
| Alligator Bioscience AB (publ) | 2.00 SEK | -1021399900.0% |
| BioInvent International AB (publ) | 11.84 Million SEK | -72.476% |
| BioArctic AB (publ) | - SEK | -Infinity% |
| Bio-Works Technologies AB (publ) | 9.06 Million SEK | -125.276% |
| Cantargia AB (publ) | - SEK | -Infinity% |
| Scandinavian ChemoTech AB (publ) | 4.03 Million SEK | -406.396% |
| CombiGene AB (publ) | -1.79 Million SEK | 1235.52% |
| Egetis Therapeutics AB (publ) | 700 Thousand SEK | -2818.286% |
| Fluicell AB (publ) | 3.15 Million SEK | -548.508% |
| Genovis AB (publ.) | 14.9 Million SEK | -37.055% |
| Hansa Biopharma AB (publ) | 9.79 Million SEK | -108.619% |
| Mendus AB (publ) | - SEK | -Infinity% |
| Karolinska Development AB (publ) | - SEK | -Infinity% |
| LIDDS AB (publ) | - SEK | -Infinity% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | - SEK | -Infinity% |
| Saniona AB (publ) | 1.00 SEK | -2042799900.0% |
| Spago Nanomedical AB (publ) | 1.00 SEK | -2042799900.0% |
| Sprint Bioscience AB (publ) | -7.13 Million SEK | 386.267% |
| Xintela AB (publ) | 398 Thousand SEK | -5032.663% |
| Amniotics AB (publ) | 534 Thousand SEK | -3725.468% |
| Corline Biomedical AB | -3.85 Million SEK | 629.634% |
| Elicera Therapeutics AB (publ) | -446.98 Thousand SEK | 4670.166% |
| Infant Bacterial Therapeutics AB (publ) | - SEK | -Infinity% |
| IRLAB Therapeutics AB (publ) | 1000.00 SEK | -2042700.0% |
| Intervacc AB (publ) | 10.48 Million SEK | -94.868% |
| Kancera AB (publ) | -1950.00 SEK | 1047689.744% |
| Lipum AB (publ) | - SEK | -Infinity% |
| Lipigon Pharmaceuticals AB (publ) | -1.62 Million SEK | 1356.335% |
| Nanologica AB (publ) | 2.97 Million SEK | -587.117% |
| Vicore Pharma Holding AB (publ) | - SEK | -Infinity% |
| Xbrane Biopharma AB (publ) | 106.85 Million SEK | 80.883% |
| AcouSort AB (publ) | 2.08 Million SEK | -882.115% |
| Diamyd Medical AB (publ) | 24.05 Million SEK | 15.06% |
| ExpreS2ion Biotech Holding AB (publ) | - SEK | -Infinity% |
| Magle Chemoswed Holding AB (publ) | 35.22 Million SEK | 42.014% |
| Modus Therapeutics Holding AB (publ) | - SEK | -Infinity% |
| Xspray Pharma AB (publ) | 43.78 Million SEK | 53.34% |
| Simris Alg AB (publ) | 1.09 Million SEK | -1772.411% |
| Ziccum AB (publ) | -4.18 Million SEK | 587.658% |
| SynAct Pharma AB | - SEK | -Infinity% |
| OncoZenge AB (publ) | -862.99 Thousand SEK | 2467.094% |
| Camurus AB (publ) | 100.95 Million SEK | 79.765% |
| 2cureX AB (publ) | -1000.00 SEK | 2042900.0% |
| Asarina Pharma AB (publ) | - SEK | -Infinity% |
| Isofol Medical AB (publ) | - SEK | -Infinity% |
| Stayble Therapeutics AB (publ) | -321.14 Thousand SEK | 6460.99% |
| I-Tech AB | 4.28 Million SEK | -377.29% |
| Cyxone AB (publ) | - SEK | -Infinity% |
| Biosergen AB | -4.92 Million SEK | 514.445% |
| Annexin Pharmaceuticals AB (publ) | - SEK | -Infinity% |
| Alzinova AB (publ) | -3.27 Million SEK | 723.185% |
| Oncopeptides AB (publ) | 2.42 Million SEK | -742.392% |
| Guard Therapeutics International AB (publ) | -1486.00 SEK | 1374797.174% |
| Pila Pharma AB (publ) | 1.00 SEK | -2042799900.0% |
| Ascelia Pharma AB (publ) | - SEK | -Infinity% |
| Diagonal Bio AB (publ) | 1.02 Million SEK | -1887.16% |